Tremfya
Tremfya ingredients
| Active ingredient | Strength |
|---|---|
| Guselkumab | 100 mg/mL, 200 mg/2mL, 200 mg/20mL |
What Tremfya is used for
The FDA lists the approved uses on the official label (below). In the EU, guselkumab is approved as Tremfya for:
Adult plaque psoriasisTremfya is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. Paediatric plaque psoriasisTremfya is indicated for the treatment of moderate to severe plaque psoriasis in children and adolescents from the age of 6 years who are candidates for systemic therapy. Psoriatic arthritisTremfya, alone or in combination with methotrexate (MTX), is indicated for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (DMARD) therapy.Ulcerative colitisTremfya is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response, or were intolerant to either conventional therapy, or a biologic treatment.Crohn’s dis…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Tremfya
- Generic name
- Guselkumab
- Made by
- Janssen Biotech, Inc.
- Forms
- Injection
- Given
- Intravenous, Subcutaneous
- Drug class
- Interleukin-23 Antagonist
- FDA approval
- Biologic licence (BLA) BLA761061
- On the US market since
- 2017
Official information
- MedlinePlus drug information (search for Guselkumab)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Tremfya?
Tremfya (Guselkumab) is a specialist medicine made by Janssen Biotech, Inc., approved by the US FDA.
What are the ingredients of Tremfya?
Tremfya contains Guselkumab (100 mg/mL, 200 mg/2mL, 200 mg/20mL).
Is Tremfya approved in Europe?
The same active substance is approved in the EU as Tremfya.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA